All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43909985" target="_blank" >RIV/00216208:11120/15:43909985 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/15:N0000005

  • Result on the web

    <a href="http://dx.doi.org/10.1136/heartjnl-2015-307686" target="_blank" >http://dx.doi.org/10.1136/heartjnl-2015-307686</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1136/heartjnl-2015-307686" target="_blank" >10.1136/heartjnl-2015-307686</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel

  • Original language description

    When considering antiplatelet therapy for acute coronary syndrome (ACS), it is essential to balance benefits (less thrombotic/ischaemic events) versus bleeding risks related to intense platelet inhibition via antagonism of P2Y(12) receptors. This analysis aimed to identify predictors of bleeding events among A Comparison of Prasugrel at the Time of PCI or as Pretreatment at the Time of Diagnosis in Patients with NSTEACS (ACCOAST) study population. The ACCOAST study randomised 4033 patients with non-ST-segment elevation myocardial infarction (NSTEMI) to (A) a 30 mg prasugrel loading dose (LD) followed by coronary angiography with an additional 30 mg prasugrel at the time of percutaneous coronary intervention (PCI) or (B) a placebo LD followed by a 60 mgprasugrel at the time of PCI. Patients received standard of care, including use of aspirin. Independent predictors of Thrombolysis in Myocardial Infarction (TIMI) major bleeding not related to coronary artery bypass grafting (CABG) withi

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Heart

  • ISSN

    1355-6037

  • e-ISSN

  • Volume of the periodical

    101

  • Issue of the periodical within the volume

    15

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    6

  • Pages from-to

    1219-1224

  • UT code for WoS article

    000357729600011

  • EID of the result in the Scopus database